Dose and Promoter Effects of Adeno-Associated Viral Vector for Green Fluorescent Protein Expression in the Rat Brain
暂无分享,去创建一个
M. King | Samuel Wang | E. Meyer | A. Hirko | J. Hughes | Yan Gong | R. Klein | Ronald L. Klein | Mary E. Hamby | Yan Gong | Aaron C. Hirko | Samuel Wang | Jeffrey A. Hughes | Michael A. King | Edwin M. Meyer
[1] H. Hauser,et al. Dicistronic transcription units for gene expression in mammalian cells. , 1993, Gene.
[2] I. Martins,et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Leff,et al. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] H. Niwa,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.
[5] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[6] T. Daly,et al. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice. , 1999, Human gene therapy.
[7] B. Byrne,et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield , 1999, Gene Therapy.
[8] C. Sumners,et al. Characterization of Glucocorticoid Type II Receptors in Neuronal and Glial Cultures from Rat Brain , 1990, Journal of neuroendocrinology.
[9] P. Colosi,et al. Distribution of AAV-TK following Intracranial Convection-Enhanced Delivery into Rats , 2000, Cell transplantation.
[10] James M. Wilson,et al. Humoral Immunity to Adeno-Associated Virus Type 2 Vectors following Administration to Murine and Nonhuman Primate Muscle , 2000, Journal of Virology.
[11] G. Breese,et al. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector , 1996, Brain Research.
[12] D. Grimm,et al. Novel tools for production and purification of recombinant adenoassociated virus vectors. , 1998, Human gene therapy.
[13] M. Dragunow,et al. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes , 2001, Gene Therapy.
[14] R. Samulski,et al. Selective and rapid uptake of adeno-associated virus type 2 in brain. , 1998, Human gene therapy.
[15] Donald W. Pfaff,et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain , 1994, Nature Genetics.
[16] M. Weitzman,et al. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. , 1999, Human gene therapy.
[17] H. Gundersen,et al. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.
[18] J. Feldon,et al. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain , 2000, Gene Therapy.
[19] Ronald L Klein,et al. Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. , 2002, Human gene therapy.
[20] M. King,et al. Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus Vectors , 1998, Experimental Neurology.
[21] R. Chen,et al. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. , 1999, Human gene therapy.
[22] R. Mandel,et al. Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system. , 2000, Advances in virus research.
[23] R. Klein,et al. Adeno-associated virus vectors: activity and applications in the CNS , 2000, Journal of Neuroscience Methods.
[24] Yamamura Ken-ichi,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .
[25] M. King,et al. Generation of aberrant sprouting in the adult rat brain by GAP-43 somatic gene transfer , 1999, Brain Research.
[26] P. Reier,et al. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters , 1997, Gene Therapy.
[27] William Jagust,et al. Convection-Enhanced Delivery of AAV Vector in Parkinsonian Monkeys; In Vivo Detection of Gene Expression and Restoration of Dopaminergic Function Using Pro-drug Approach , 2000, Experimental Neurology.
[28] M. King,et al. Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain , 1999, Neuroscience.